Fungal Pneumonia Treatment Market

  The forecast period is expected to witness a steady revenue Compound Annual Growth Rate (CAGR) in the global Fungal Pneumonia Treatment Market . The growth in revenue is primarily driven by the increasing incidence of pneumonia and the rise in the prevalence of community-acquired pneumonia, particularly among the younger population. Fungal pneumonia is a rare lung infection caused by fungi. It can be caused by endemic, opportunistic, or a combination of both types of fungi. This infection mainly affects individuals with compromised immune systems, such as those with Human Immunodeficiency Virus (HIV), Acquired Immunodeficiency Syndrome (AIDS), diabetes, or leukemia. A properly functioning immune system typically prevents fungi from attacking living tissues. Pneumocystis pneumonia, caused by Pneumocystis jirovecii, is the most serious and common fungal infection. It primarily affects individuals with weakened immune systems, including those with AIDS. While deep fungal infecti...